The ileocolic intussusception clinical pathway is a detailed care plan that outlines the necessary steps in treating a healthy child with suspected ileocolic intussusception without a pathologic lead point in the emergency department.

This pathway will guide the evaluation and treatment of a pediatric patient admitted with probable anti-NMDAR encephalitis

This pathway is intended to support providers caring for children with prolonged QTc identified on ECG. Stratifications of QTC interval measurements provide guidance for care delivery. Recommendations include escalating urgent and emergent support for medical management and continued monitoring for the goal of prevention of Torsades de Pointes.

The hyperbilirubinemia pathway is a standard approach to initial evaluation, treatment, and management of infants with hyperbilirubinemia from birth through 21 days of life.

This pathway should be used to guide the evaluation and treatment of patients with fever and recent travel. ≥ 38 °C in a traveler within 30 days of return to the U.S.

This pathway guides the care of children who present with onset of flaccid weakness in one or more extremities +/- bulbar/cranial nerve findings without other clear cause. 

The PICU central diabetes insipidus pathway provides guidance for the care of patients with known or suspected central diabetes insipidus requiring ICU care.

The unprovoked seizure clinical pathway outlines the steps to standardize the ED clinical assessment, evaluation and recommend Neurology follow-up for healthy children presenting with new onset unprovoked seizure(s).

The Infant Malnutrition (Failure to Thrive) Pathway provides a consistent approach to caring for infants at risk for malnutrition in the outpatient setting.

Peri- procedure and post-procedure calcium surveillance and management for pediatric patients with 22q11.2 diagnosis.